After the capital increase, the total nominal value of Bavarian Nordic A/S' share capital is DKK 788,548,570, which is made up of 78,854,857 shares of a nominal value of DKK 10 each, corresponding to ...
ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response ...
Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.
Les horloges circadiennes moléculaires du cerveau et des tissus musculaires se coordonnent et leur synchro est nécessaire ...